Creon Use in Coeliac Patients With Low Faecal Pancreatic Elastase
Launched by SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST · May 28, 2013
Trial Information
Current as of May 13, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients with coeliac disease and having chronic diarrhoea (\>3 loose/ liquid motions a day for more than 4 weeks)
- • Patients with a low faecal elastase (\<200 ug/g),
- • Patients aged 16 years or over
- • Patient able to give written consent to participate
- • Patient not currently on Creon
- Exclusion Criteria:
- • Patients with normal faecal elastase (\> 201ug/g),
- • Patients under the age of 16
- • Patients allergic to pork or any pig product (advice from the drug manufacturer)
- • Patients that are pregnant or are breast-feeding
- • Patients taking alternative medication that could affect bowel frequency
- • Where an alternative diagnosis for the chronic diarrhoea is established, these patients will be excluded from the trial
- • Patients who are unable to speak or understand English
About Sheffield Teaching Hospitals Nhs Foundation Trust
Sheffield Teaching Hospitals NHS Foundation Trust is a leading healthcare institution in the UK, dedicated to delivering high-quality patient care, advancing medical research, and fostering education and training in the health sector. As a prominent sponsor of clinical trials, the Trust collaborates with various stakeholders to facilitate innovative research initiatives that aim to improve treatment outcomes and enhance patient safety. With a commitment to excellence, the organization leverages its extensive clinical expertise and resources to support the development of new therapies and interventions, ultimately contributing to the advancement of healthcare practices both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sheffield, South Yorkshire, United Kingdom
Patients applied
Trial Officials
David S Sanders, FRCP
Principal Investigator
Sheffield Teaching Hospitals NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials